For patients reporting GI PASC, SARS-CoV-2-specific CD8+ T cells exhibited undifferentiated phenotypes during acute disease and elevated cytotoxic characteristics at T3 (Figure 4C). The gene discussed is CD8A; the disease is long COVID-19.